These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11696685)

  • 1. Reversal of endothelial dysfunction in humans.
    Hornig B; Drexler H
    Coron Artery Dis; 2001 Sep; 12(6):463-73. PubMed ID: 11696685
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endothelial nitric oxide and physical activity in cardiovascular diseases].
    Nonas M; Jegier A
    Pol Arch Med Wewn; 2004 Jun; 111(6):749-55. PubMed ID: 15508800
    [No Abstract]   [Full Text] [Related]  

  • 3. Endothelial function and oxidative stress in cardiovascular diseases.
    Higashi Y; Noma K; Yoshizumi M; Kihara Y
    Circ J; 2009 Mar; 73(3):411-8. PubMed ID: 19194043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endothelial dysfunction and metabolic effects of nitric oxide in human].
    Kolesnichenko OIu; Filatova LM; Krivitsina ZA; Voronkov IuI
    Fiziol Cheloveka; 2003; 29(5):74-81. PubMed ID: 14611088
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitric oxide metabolites and cardiovascular disease markers, mediators, or both?
    Lundberg JO
    J Am Coll Cardiol; 2006 Feb; 47(3):580-1. PubMed ID: 16458139
    [No Abstract]   [Full Text] [Related]  

  • 6. [The diagnostic value of endothelium-dependent vasodilation. The functional unity of endothelin, nitric oxide, and formation of function in phylogenesis].
    Titov VN
    Klin Lab Diagn; 2009 Feb; (2):3-16. PubMed ID: 19338087
    [No Abstract]   [Full Text] [Related]  

  • 7. Contemporary Approaches to Modulating the Nitric Oxide-cGMP Pathway in Cardiovascular Disease.
    Kraehling JR; Sessa WC
    Circ Res; 2017 Mar; 120(7):1174-1182. PubMed ID: 28360348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms of nitric oxide activity in cardiovascular system as a basis of pathogenetic therapy of related diseases].
    Moĭbenko OO; Sahach VF; Tkachenko MM; Korkushko OV; Bezrukov VV; Kul'chyts'kyĭ OK; Stefanov OV; Solovĭov AI; Mala LT; Frol'kis VV
    Fiziol Zh (1994); 2004; 50(1):11-30. PubMed ID: 14965048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
    Böger RH; Ron ES
    Altern Med Rev; 2005 Mar; 10(1):14-23. PubMed ID: 15771559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Editor's Roundtable: Endothelial dysfunction in cardiovascular disease.
    Friedewald VE; Giles TD; Pool JL; Yancy CW; Roberts WC
    Am J Cardiol; 2008 Aug; 102(4):418-23. PubMed ID: 18678298
    [No Abstract]   [Full Text] [Related]  

  • 11. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension.
    Brunner H; Cockcroft JR; Deanfield J; Donald A; Ferrannini E; Halcox J; Kiowski W; Lüscher TF; Mancia G; Natali A; Oliver JJ; Pessina AC; Rizzoni D; Rossi GP; Salvetti A; Spieker LE; Taddei S; Webb DJ;
    J Hypertens; 2005 Feb; 23(2):233-46. PubMed ID: 15662207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How We Learned to Say NO.
    Vanhoutte PM
    Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1156-60. PubMed ID: 19605779
    [No Abstract]   [Full Text] [Related]  

  • 13. Nitric oxide signaling in the cardiovascular system--physiology and pathology.
    Malinski T
    Postepy Hig Med Dosw; 1999; 53(2):205-7. PubMed ID: 10355286
    [No Abstract]   [Full Text] [Related]  

  • 14. Nitric oxide and the endothelium: history and impact on cardiovascular disease.
    Yetik-Anacak G; Catravas JD
    Vascul Pharmacol; 2006 Nov; 45(5):268-76. PubMed ID: 17052961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular Ageing and Exercise: Focus on Cellular Reparative Processes.
    Ross MD; Malone E; Florida-James G
    Oxid Med Cell Longev; 2016; 2016():3583956. PubMed ID: 26697131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide bioavailability dysfunction involves in atherosclerosis.
    Chen JY; Ye ZX; Wang XF; Chang J; Yang MW; Zhong HH; Hong FF; Yang SL
    Biomed Pharmacother; 2018 Jan; 97():423-428. PubMed ID: 29091892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities.
    Le Brocq M; Leslie SJ; Milliken P; Megson IL
    Antioxid Redox Signal; 2008 Sep; 10(9):1631-74. PubMed ID: 18598143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction and cardiovascular risk factors.
    Grover-Páez F; Zavalza-Gómez AB
    Diabetes Res Clin Pract; 2009 Apr; 84(1):1-10. PubMed ID: 19185380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide, an iceberg in cardiovascular physiology: far beyond vessel tone control.
    Rubio AR; Morales-Segura MA
    Arch Med Res; 2004; 35(1):1-11. PubMed ID: 15036793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenetic pharmacotherapy of erectile dysfunction].
    Dorofeev SD; Paniushkin SM; Efremov EA
    Urologiia; 2007; (3):107-11. PubMed ID: 17722630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.